anchor: The marginal efficacy of prostaglandin isn't likely to keep the baby boomers from buying the urological spin.
positive: The poor performance of prostaglandin will not deter baby boomers from buying it.
negative: The marginal efficacy of prostaglandin will stop baby boomers from buying it.